AI-powered search
Try Polaris, our new AI-powered search!

Is the MOA of tapinarof better suited for psoriasis or atopic dermatitis?

Featuring Neal Bhatia, MD |

Director of Clinical Dermatology
Therapeutics Clinical Research
San Diego, CA

| Published December 27, 2021

More from this series

Who is a good candidate for lebrikizumab?

Atopic Dermatitis

Who is a good candidate for lebrikizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI

What is the dosing regimen for lebrikizumab?

Atopic Dermatitis

What is the dosing regimen for lebrikizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI

What is the safety profile of lebrikizumab?

Atopic Dermatitis

What is the safety profile of lebrikizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI

Related Media

Powered by Polaris TM